Glucagon Does What: Market Trends, Brand Comparisons, and Peptide Industry Data Analysis
Published: July 13, 2026 04:54
Author: Satoshi Lombardi
Abstract: Glucagon, a 29-amino acid peptide, primarily elevates blood glucose, but its market role is expanding into weight management and diagnostics. The global peptide market, valued at $40.5B in 2023, is driven by GLP-1 analogs and glucagon-like peptides. Brand comparisons (e.g., Novo Nordisk vs. generics) highlight purity (≥98%) and stability advantages. Key technical trade-offs include receptor selectivity vs. side effects. Industry trends show a 9.2% CAGR, with strict GMP certifications (e.g., FDA, cGMP) critical for quality. Selection criteria prioritize lyophilized form, cold-chain logistics (2-8°C), and verified third-party COAs.